v3.25.1
Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 1,281,141 $ 1,600,741
General and administrative 1,058,662 1,602,819
Total operating expenses 2,339,803 3,203,560
Loss from operations (2,339,803) (3,203,560)
Other income and expenses:    
Interest income 36,216 69,298
Net loss $ (2,303,587) $ (3,134,262)
Net loss per share of Common Stock, basic $ (0.45) $ (7.06)
Net loss per share of Common Stock, diluted $ (0.45) $ (7.06)
Weighted-average basic Common Stock 5,154,698 443,998
Weighted-average diluted Common Stock 5,154,698 443,998

Source